Recorded
Wednesday, September 29, 2021 · 2:30 p.m.
Pioneering Research in E3 Ubiquitin Ligase Biology and Applications to Drug Discovery
Recorded
Wednesday, September 29, 2021 · 2:30 p.m.
ABOUT THIS WEBINAR
Approximately 40% of human diseases may be attributable to defects in the cellular proteostasis machinery, including the ubiquitin-proteasome system. Accumulation of misfolded, damaged, or aggregated proteins can lead to prolonged stress, accumulation of reactive oxygen species, and cell death. In this webinar, brought to you by Bio-Techne, Jennifer Johnston will discuss how her research of ubiquitin-proteasome system elements, including Parkin E3 ligase, is used to diagnose and treat diseases caused by defects in proteostasis pathways.
Topics to be covered
• The basics of the ubiquitin-proteasome system
• The biology and druggability of ubiquitin E3 ligases
• Modifications of ubiquitin proteins and their therapeutic and diagnostic applications
Education & learning
ADDITIONAL INFO
Categories:
Education & learning
When:
Wednesday, September 29, 2021 · 2:30 p.m.
Eastern Time (US & Canada)
Duration: 1 hour
Price:Free
Language:English
Who can attend?Anyone with the event link can attend
Dial-in available?
(listen only):Yes.
Dial-in Number:
Please register for this Webinar to view the dial-in info.
Jennifer is the creative force behind NysnoBio, responsible for the business and scientific focus of the company as CEO. She has over 20 years of experience in the biopharmaceutical industry, including 13 years in neurodegenerative diseases at...